Schisandrin B Ameliorates ICV-Infused Amyloid β Induced Oxidative Stress and Neuronal Dysfunction through Inhibiting RAGE/NF-κB/MAPK and Up-Regulating HSP/Beclin Expression

Amyloid β (Aβ)-induced neurotoxicity is a major pathological mechanism of Alzheimer’s disease (AD). Our previous studies have demonstrated that schisandrin B (Sch B), an antioxidant lignan from Schisandra chinensis, could protect mouse brain against scopolamine- and cisplatin-induced neuronal dysfunction. In the present study, we examined the protective effect of Sch B against intracerebroventricular (ICV)-infused Aβ-induced neuronal dysfunction in rat cortex and explored the potential mechanism of its action. Our results showed that 26 days co-administration of Sch B significantly improved the behavioral performance of Aβ (1–40)-infused rats in step-through test. At the same time, Sch B attenuated Aβ-induced increases in oxidative and nitrosative stresses, inflammatory markers such as inducible nitric oxide syntheses, cyclooxygenase-2, interleukin-1β (IL-1β), IL-6, and tumor necrosis factor-α, and DNA damage. Several proteins such as receptor for advanced glycation end products (RAGE), nuclear factor-κB, mitogen-activated protein kinases, and apoptosis markers were over expressed in Aβ-infused rats but were significantly inhibited by Sch B treatment. Furthermore, Sch B negatively modulated the Aβ level with simultaneous up-regulation of HSP70 and beclin, autophagy markers in Aβ-infused rats. The aforementioned effects of Sch B suggest its protective role against Aβ-induced neurotoxicity through intervention in the negative cycle of RAGE-mediated Aβ accumulation during AD patho-physiology.

[1]  C. Behl,et al.  Amyloid peptides are toxic via a common oxidative mechanism. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[2]  L. V. Van Eldik,et al.  P4-428 Glia as a therapeutic target: Selective suppression of human amyloid-beta-induced upregulation of brain proinflammatory cytokine production attenuates neurodegeneration , 2006, Alzheimer's & Dementia.

[3]  G. Ellman,et al.  Tissue sulfhydryl groups. , 1959, Archives of biochemistry and biophysics.

[4]  K. Davis.  Cholinesterase Inhibitors in Alzheimer's Disease , 1994, Neuropsychopharmacology.

[5]  Xiongwei Zhu,et al.  Compensatory responses induced by oxidative stress in Alzheimer disease. , 2006, Biological research.

[6]  T. Nabeshima,et al.  Memory impairment induced by chronic intracerebroventricular infusion of beta-amyloid (1–40) involves downregulation of protein kinase C , 2002, Brain Research.

[7]  Ping Liu,et al.  Baicalin Attenuates Brain Edema in a Rat Model of Intracerebral Hemorrhage , 2013, Inflammation.

[8]  R C Chaubey,et al.  Gamma ray induced DNA damage in human and mouse leucocytes measured by SCGE-Pro: a software developed for automated image analysis and data processing for Comet assay. , 2001, Mutation research.

[9]  L. V. Van Eldik,et al.  Human amyloid beta-induced neuroinflammation is an early event in neurodegeneration. , 2006, Glia.

[10]  P. Shaw,et al.  Protective effects of dibenzocyclooctadiene lignans from Schisandra chinensis against beta‐amyloid and homocysteine neurotoxicity in PC12 cells , 2010, Phytotherapy research : PTR.

[11]  Heng Du,et al.  RAGE is a key cellular target for Abeta-induced perturbation in Alzheimer's disease. , 2012, Frontiers in bioscience.

[12]  L. V. Van Eldik,et al.  Glia as a Therapeutic Target: Selective Suppression of Human Amyloid-β-Induced Upregulation of Brain Proinflammatory Cytokine Production Attenuates Neurodegeneration , 2006, The Journal of Neuroscience.

[13]  J. Hancke,et al.  Use of visual analogue scale measurements (VAS) to asses the effectiveness of standardized Andrographis paniculata extract SHA-10 in reducing the symptoms of common cold. A randomized double blind-placebo study. , 1999, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[14]  D. Selkoe,et al.  The seminal role of beta-amyloid in the pathogenesis of Alzheimer disease. , 1992, Alzheimer disease and associated disorders.

[15]  Hyoung-Chun Kim,et al.  Loganin improves learning and memory impairments induced by scopolamine in mice. , 2009, European journal of pharmacology.

[16]  G. Schieven.  The biology of p38 kinase: a central role in inflammation. , 2005, Current topics in medicinal chemistry.

[17]  K. Yagi,et al.  Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. , 1979, Analytical biochemistry.

[18]  D. Heistad,et al.  Spontaneous Intracerebral Hemorrhage during Acute and Chronic Hypertension in Mice , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[19]  Nicholas E. Bruns,et al.  A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy , 2008, Proceedings of the National Academy of Sciences.

[20]  Anthony J. Muslin,et al.  Modulation of doxorubicin-induced cardiac dysfunction in dominant-negative p38α mitogen-activated protein kinase mice. , 2010, Free radical biology & medicine.

[21]  X. Tang,et al.  Huperzine A attenuates cognitive dysfunction and neuronal degeneration caused by beta-amyloid protein-(1-40) in rat. , 2001, European journal of pharmacology.

[22]  P. Reddy.  Amyloid precursor protein‐mediated free radicals and oxidative damage: Implications for the development and progression of Alzheimer's disease , 2006, Journal of neurochemistry.

[23]  K. Hirata,et al.  Angiotensin II type 1 receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice. , 2006, Atherosclerosis.

[24]  D. Butterfield,et al.  Involvement of PI3K/PKG/ERK1/2 signaling pathways in cortical neurons to trigger protection by cotreatment of acetyl-L-carnitine and alpha-lipoic acid against HNE-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease. , 2007, Free radical biology & medicine.

[25]  T. Hasegawa,et al.  β-Amyloid protein-induced Alzheimer's disease animal model , 1994, Neuroscience Letters.

[26]  Dejian Huang,et al.  Analysis of antioxidant activities of common vegetables employing oxygen radical absorbance capacity (ORAC) and ferric reducing antioxidant power (FRAP) assays: a comparative study. , 2002, Journal of agricultural and food chemistry.

[27]  L. Barbeito,et al.  The molecular bases of Alzheimer's disease and other neurodegenerative disorders. , 2001, Archives of medical research.

[28]  A. Schmidt,et al.  RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. , 1996, Nature.

[29]  C. Grandi,et al.  Involvement of the receptor for advanced glycation-end products (RAGE) in beta-amyloid-induced toxic effects in rat cerebromicrovascular endothelial cells cultured in vitro. , 2009, International journal of molecular medicine.

[30]  V. Srikanth,et al.  Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease , 2011, Neurobiology of Aging.

[31]  G. Segonzac,et al.  [Colorimetric determination of acetylcholine by the Hestrin hydroxylamine reaction and its application in pharmacy]. , 1958, Annales pharmaceutiques francaises.

[32]  Michio Hashimoto,et al.  Docosahexaenoic acid-induced amelioration on impairment of memory learning in amyloid beta-infused rats relates to the decreases of amyloid beta and cholesterol levels in detergent-insoluble membrane fractions. , 2005, Biochimica et biophysica acta.

[33]  B. Zlokovic,et al.  Blood-brain barrier transport of circulating Alzheimer's amyloid beta. , 1993, Biochemical and biophysical research communications.

[34]  K. Courtney,et al.  A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.

[35]  Liu Gt.  Pharmacological actions and clinical use of fructus schizandrae. , 1989 .

[36]  T. Hasegawa,et al.  Continuous infusion of beta-amyloid protein into the rat cerebral ventricle induces learning impairment and neuronal and morphological degeneration. , 1998, Japanese journal of pharmacology.

[37]  S Moncada,et al.  Differential effect of nitric oxide on glutathione metabolism and mitochondrial function in astrocytes and neurones: implications for neuroprotection/neurodegeneration? , 2003, Journal of neurochemistry.

[38]  A. Phillips,et al.  A case for a non‐transgenic animal model of Alzheimer's disease , 2005, Genes, brain, and behavior.

[39]  Y. Jang,et al.  Protopine from Corydalis ternata has anticholinesterase and antiamnesic activities. , 1999, Planta medica.

[40]  Horng-mo Lee,et al.  Advanced glycosylation end products induce inducible nitric oxide synthase (iNOS) expression via a p38 MAPK-dependent pathway. , 2004, Kidney international.

[41]  G. Sobue,et al.  Advanced glycation end products co-localized with astrocytes and microglial cells in Alzheimer’s disease brain , 1998, Acta Neuropathologica.

[42]  R. Tice,et al.  Single cell gel/comet assay: Guidelines for in vitro and in vivo genetic toxicology testing , 2000, Environmental and molecular mutagenesis.

[43]  J. Morris,et al.  Cholinesterase Inhibitors for Alzheimer’s Disease , 2012, Drugs.

[44]  N. Inestrosa,et al.  Structure-function implications in Alzheimer's disease: effect of Abeta oligomers at central synapses. , 2008, Current Alzheimer research.

[45]  X. Chen,et al.  RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease , 1996, Nature.

[46]  X. Yao,et al.  Effects of oolong tea on plasma antioxidative capacity in mice loaded with restraint stress assessed using the oxygen radical absorbance capacity (ORAC) assay. , 2004, Biological & pharmaceutical bulletin.

[47]  B. Zlokovic,et al.  Blood-brain barrier transport of circulating Alzheimer's amyloid beta. , 1993, Biochemical and biophysical research communications.

[48]  A. Schmidt,et al.  The biology of the receptor for advanced glycation end products and its ligands. , 2000, Biochimica et biophysica acta.

[49]  Brian Spencer,et al.  The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. , 2008, The Journal of clinical investigation.

[50]  V. Papadopoulos,et al.  Identification of naturally occurring spirostenols preventing β-amyloid-induced neurotoxicity , 2004, Steroids.

[51]  D. Selkoe,et al.  The Seminal Role of β‐Amyloid in the Pathogenesis of Alzheimer Disease , 1992 .

[52]  K. Rockwood,et al.  Differential effects of lipid-lowering agents on human cholinesterases. , 2004, Clinical biochemistry.

[53]  L. V. Van Eldik,et al.  Human amyloid β‐induced neuroinflammation is an early event in neurodegeneration , 2006 .

[54]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[55]  D. Mak,et al.  Hepatoprotective mechanism of schisandrin B: role of mitochondrial glutathione antioxidant status and heat shock proteins. , 2003, Free radical biology & medicine.

[56]  L. Lue,et al.  Involvement of Microglial Receptor for Advanced Glycation Endproducts (RAGE) in Alzheimer's Disease: Identification of a Cellular Activation Mechanism , 2001, Experimental Neurology.

[57]  S. Nam,et al.  l-Theanine, an amino acid in green tea, attenuates beta-amyloid-induced cognitive dysfunction and neurotoxicity: reduction in oxidative damage and inactivation of ERK/p38 kinase and NF-kappaB pathways. , 2009, Free radical biology & medicine.

[58]  C. Scavone,et al.  Altered KLOTHO and NF-κB-TNF-α Signaling Are Correlated with Nephrectomy-Induced Cognitive Impairment in Rats , 2015, PloS one.

[59]  S. Tannenbaum,et al.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. , 1982, Analytical biochemistry.

[60]  K. Ko,et al.  Schisandrin B protects myocardial ischemia-reperfusion injury partly by inducing Hsp25 and Hsp70 expression in rats , 2004, Molecular and Cellular Biochemistry.

[61]  J. Glenn,et al.  Distribution of the receptor for advanced glycation end products in the human male reproductive tract: prevalence in men with diabetes mellitus. , 2007, Human reproduction.

[62]  R. Thandavarayan,et al.  Prevention of scopolamine-induced memory deficits by schisandrin B, an antioxidant lignan from Schisandra chinensis in mice , 2011, Free radical research.